Taken together, it seems biologically plausible that the SOD3 R213G variant, by drastically reducing tissue affinity of the SOD3 enzyme and leaving the vascular tissue with low protection against superoxide radicals, may increase the risk of cardiovascular disease and heart failure. Here, SOD3 is linked to heart failure.